The German Shepherd is among the most beloved dog breeds in the United States, admired for its impressive size, adaptability, and intelligence. This breed thrives in many roles—from devoted family companions and service animals to highly skilled competitors in canine sports—thanks to their eager trainability and quick responsiveness.
However, decades of selective breeding have unfortunately led to some hereditary health issues in German Shepherds. One significant inherited immune disorder to be aware of is leukocyte adhesion deficiency type III (LAD III). To ensure the health and vitality of this cherished breed, it’s crucial to select dogs carefully and utilize DNA tests to screen for genetic conditions.
LAD III is a hereditary blood disorder caused by mutations in the FERMT3 gene. This mutation disrupts the normal function of white blood cells (leukocytes), hindering their ability to travel effectively to sites of infections or injuries. As a result, affected German Shepherds often experience frequent, stubborn infections that don’t respond well to antibiotic treatment.
Although these dogs may appear outwardly healthy, even minor cuts or bruises heal poorly due to a weakened immune system and reduced blood clotting capacity. This condition also poses challenges during surgery, often necessitating blood transfusions because of the risks involved.
The inheritance follows an autosomal recessive pattern, where a dog needs to inherit two copies of the mutated gene—one from each parent—to develop the disorder. Dogs carrying just one copy of the mutation are healthy carriers who can pass the gene to their puppies without showing symptoms themselves.
Depending on the genetic makeup of the breeding pair, the outcomes for the puppies vary as follows:
To advance responsible breeding and minimize LAD III's prevalence in German Shepherds, DNA testing of all breeding dogs is strongly advised. Such testing clarifies whether a dog is clear, a carrier, or affected by the mutation.
The testing process is straightforward and involves collecting a DNA sample by a licensed veterinarian—usually by drawing blood into an EDTA tube or taking cheek swabs. Samples are then sent to specialized labs like those offered by various US veterinary diagnostic services providing PCR or gene sequencing tests for the FERMT3 mutation. Results are typically returned within 1 to 2 weeks.
Knowing the genetic status allows breeders in the US to make informed mating decisions, preventing carrier-to-carrier or carrier-to-affected breedings and ultimately reducing the incidence of LAD III puppies.
Breeders are encouraged to use LAD III DNA test results to guide breeding choices carefully:
This balanced approach supports genetic health and variation, working toward gradually eliminating LAD III within the breed population.
Leukocyte adhesion deficiency type III is a serious, inherited immune disorder affecting German Shepherds' ability to combat infections and heal wounds effectively. DNA testing for LAD III is a powerful resource for breeders devoted to producing strong, healthy pups while responsibly managing the breed's genetic health.
If you plan on finding a German Shepherd puppy or are a breeder preparing for a litter, speak with your US veterinarian about LAD III DNA testing. Protect your dogs and puppies from this hereditary condition with informed choices.